89
Participants
Start Date
January 14, 2016
Primary Completion Date
May 16, 2017
Study Completion Date
May 16, 2017
Nintedanib
Participants with IPF will receive nintedanib at the 200-300 mg/day dose up to 24 weeks.
Pirfenidone
Participants with IPF will receive pirfenidone at 1602-2403 mg/day dose up to 24 weeks.
Gentofte Hospital, Lungemedicinsk Afdeling, Hellerup
Mount Sinai School of Medicine, New York
Columbia University Medical Center, New York
A.O. Universitaria San Luigi Gonzaga di Orbassano; Malattie Apparato Respiratorio (MAR2), Orbassano
ASST DI MONZA; U O Clinica Pneumologica, Monza
Inova Health Care Services; Advanced Lung Disease Transplant Program, Falls Church
Complejo Asistencial Universitario de Leon; Pneumology, León
Pulmonix LLC, Greensboro
Hospital Universitario La Princesa; Servicio de Neumologia, Madrid
Hospital del Henares; Medicina Interna. Unidad de Neumología, Coslada (Madrid)
Medical University of South Carolina (MUSC); MUSC Pulmonary, Charleston
Sarasota Memorial Hospital, Sarasota
Hopital de Pontchaillou; Service de Pneumologie, Rennes
Klinikum Fulda gAG; Universitätsmedizin Marburg, Campus Fulda, Fulda
Vanderbilt University Medical Center, Nashville
Hospital Universitario de Canarias; Servicio de Neumologia, San Cristóbal de La Laguna
Hospital Universitario Virgen del Rocio; Servicio de Neumologia, Seville
Ruhrlandklinik Lungenzentrum der UNI Essen Abt.Pneumologie-Allergologie, Essen
UC Health Clinical Trials Office, Cincinnati
Hospital General Universitario De Valencia; Servicio de Neumologia, Valencia
A.O. Univ. Senese Policlinico S. Maria alle Scotte; UOC Malattie Resepiratorie e Trapianto Polmonare, Siena
Azienda Ospedaliero Universitaria Pisana; U.O. Pneumologia, Pisa
Cardio-Pulmonary Associates of St. Luke's Hospital, Chesterfield
Creighton University, Omaha
Hopital Louis Pradel; Pneumologie, Bron
Hopital Avicenne; Pneumologie, Bobigny
Stanford University School of Medicine ; Pulmonary/Critical Care Medicine, Stanford
John A. Butler, M.D. - Oregon Pulmonary Associates, Portland
David Geffen School of Medicine at UCLA;Division of Pulmonary & Critical Care/ Department of Medic, Los Angeles
Beth Israel Deaconess Medical Center, Boston
University of Michigan Health System, Ann Arbor
Atlantic Respiratory Institute, Summit
South Health Campus/Alberta Health Services/ University of Calgary, Calgary
University Health Network, Toronto
Fachkrankenhaus Coswig GmbH Zentrum f.Pneumologie Beatmungsmedizin Thorax-u.Gefäßchirurgie, Coswig
Antonius Ziekenhuis; Dept of Lung Diseases, Nieuwegein
Erasmus MC; Afdeling Longziekten, Rotterdam
Hospital Universitari de Bellvitge ; Servicio de Neumologia, L'Hospitalet de Llobregat
Hoffmann-La Roche
INDUSTRY